Stock SRDX SURMODICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Surmodics, Inc.

Equities

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
34.62 USD +1.58% Intraday chart for Surmodics, Inc. +7.65% -4.76%
May. 02 Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating MT
May. 01 Top Midday Gainers MT

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 617.1 531.1 771.3 425.8 453.6 493.7 - -
Enterprise Value (EV) 1 617.1 531.1 771.3 425.8 453.6 493.7 493.7 493.7
P/E ratio 83.2 x 486 x 185 x -15.5 x -292 x -44.5 x -223 x 277 x
Yield - - - - - - - -
Capitalization / Revenue 6.17 x 5.6 x 7.34 x 4.26 x 3.42 x 4.02 x 3.59 x 3.2 x
EV / Revenue 6.17 x 5.6 x 7.34 x 4.26 x 3.42 x 4.02 x 3.59 x 3.2 x
EV / EBITDA 43.7 x 92.1 x 64.2 x -33.1 x 32.7 x 53.4 x 33.9 x 21.5 x
EV / FCF 302 x 51.4 x 76.3 x -20.7 x 59.7 x -48.6 x 29.5 x 18.7 x
FCF Yield 0.33% 1.95% 1.31% -4.84% 1.67% -2.06% 3.39% 5.34%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 13,491 13,650 13,872 14,005 14,134 14,260 - -
Reference price 2 45.74 38.91 55.60 30.40 32.09 34.62 34.62 34.62
Announcement Date 10/31/19 11/4/20 11/10/21 11/9/22 11/8/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 100.1 94.86 105.1 99.95 132.6 122.9 137.5 154.2
EBITDA 1 14.13 5.765 12.02 -12.85 13.87 9.241 14.57 22.94
EBIT 1 6.469 -1.251 6.703 -22.1 5.603 -7.556 -0.5098 3.738
Operating Margin 6.46% -1.32% 6.38% -22.11% 4.23% -6.15% -0.37% 2.42%
Earnings before Tax (EBT) 1 7.558 -1.454 6.346 -22.49 2.487 -10.65 -2.717 0.8635
Net income 1 7.592 1.123 4.237 -27.27 -1.536 -11.04 -2.316 1.819
Net margin 7.59% 1.18% 4.03% -27.29% -1.16% -8.98% -1.68% 1.18%
EPS 2 0.5500 0.0800 0.3000 -1.960 -0.1100 -0.7775 -0.1550 0.1250
Free Cash Flow 1 2.04 10.34 10.11 -20.59 7.596 -10.15 16.74 26.34
FCF margin 2.04% 10.9% 9.62% -20.6% 5.73% -8.26% 12.17% 17.08%
FCF Conversion (EBITDA) 14.44% 179.34% 84.1% - 54.75% - 114.86% 114.82%
FCF Conversion (Net income) 26.87% 920.66% 238.61% - - - - 1,447.94%
Dividend per Share - - - - - - - -
Announcement Date 10/31/19 11/4/20 11/10/21 11/9/22 11/8/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 23 26.11 24.85 25.99 24.93 27.2 52.48 27.97 30.55 31.96 29.95 30.5 33.2 34.99 35.13
EBITDA 1 -1.032 -2.578 -4.852 -4.39 -5.232 -3.284 23.5 -0.283 1.966 4.809 0.6375 0.5017 3.091 3.885 5.108
EBIT 1 -3.441 -4.9 -7.143 -6.613 -7.229 -5.301 21.41 -2.45 -0.322 0.659 -4.075 -3.799 -0.4677 0.2233 1.222
Operating Margin -14.96% -18.77% -28.74% -25.45% -28.99% -19.49% 40.8% -8.76% -1.05% 2.06% -13.6% -12.46% -1.41% 0.64% 3.48%
Earnings before Tax (EBT) 1 -3.518 -5.002 -7.181 -6.792 -8.008 -7.365 20.65 -2.789 -0.724 0.166 -5.162 -4.912 -0.9077 -0.2 0.8317
Net income 1 -2.812 -4.083 -5.651 -14.73 -7.843 -7.733 7.346 6.694 -0.786 0.247 -5.434 -5.086 -1.073 -0.389 0.604
Net margin -12.22% -15.64% -22.74% -56.67% -31.46% -28.43% 14% 23.93% -2.57% 0.77% -18.14% -16.68% -3.23% -1.11% 1.72%
EPS 2 -0.2000 -0.2900 -0.4100 -1.060 -0.5600 -0.5500 0.5200 0.4700 -0.0600 0.0200 -0.3825 -0.3600 -0.0733 -0.0233 0.0467
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/3/22 4/27/22 7/27/22 11/9/22 2/6/23 4/26/23 8/2/23 11/8/23 2/1/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 2.04 10.3 10.1 -20.6 7.6 -10.1 16.7 26.3
ROE (net income / shareholders' equity) - 0.89% 3.13% -22% - -9.1% 7.5% -
ROA (Net income/ Total Assets) - - - -15.5% - -11.7% 5.2% -
Assets 1 - - - 176.5 - 94.36 -44.53 -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 6 3.67 5.28 3.37 2.92 4.74 4.75 6
Capex / Sales 5.99% 3.87% 5.02% 3.37% 2.2% 3.86% 3.45% 3.89%
Announcement Date 10/31/19 11/4/20 11/10/21 11/9/22 11/8/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Surmodics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.62 USD
Average target price
58.25 USD
Spread / Average Target
+68.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SURMODICS, INC. Stock Surmodics, Inc.
-4.76% 494M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.43% 181B
MEDTRONIC PLC Stock Medtronic plc
+4.30% 114B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.09% 68.29B
DEXCOM, INC. Stock DexCom, Inc.
+5.86% 52.24B
CENCORA, INC. Stock Cencora, Inc.
+8.15% 44.3B
HOYA CORPORATION Stock Hoya Corporation
+6.67% 42.73B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+25.54% 32.52B
TERUMO CORPORATION Stock Terumo Corporation
+20.03% 26.02B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.00% 25.91B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SRDX Stock
  4. Financials Surmodics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW